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1. Introduction 
Contact allergy (CA), a pathologic response after (usually repeated) contact to 
environmental substances of low molecular weight occurring in a varying proportion of 
exposed persons, often results in clinical disease, allergic contact dermatitis (ACD), which 
can be disabling. CA is diagnosed by patch testing, a technique of controlled exposure of 
patients suspected to have ACD to a standardized set of substances frequently found to be 
the cause of ACD (Uter, 2004). ACD is an inflammatory reaction of the skin that follows 
percutaneous absorption of antigen from the skin surface and recruitment of previously 
sensitized, antigen-specific T lymphocytes into the skin (Rietschel & Fowler, 2001a). 
Although sensitivity to contact allergens occurs in 10-20% of the adult population, the exact 
incidence and prevalence of sensitization in children is unknown. ACD in children is not 
rare. The documented rates of ACD in children are on the increase (Militello et al., 2006; 
Goossens & Morren, 2006). Sensitization to contact allergens begins in infancy and continues 
to be more common in toddlers and young children. Infants, even neonates, may be 
sensitized (Fisher, 1994a; Bruckner et al., 2000). The rate of positive results may vary with 
referral patterns, selection criteria for patch testing, regional and social variations in 
allergens exposure and the allergen tested (Militello et al., 2006; Goossens & Morren, 2006; 
Wahlberg & Lindgerg, 2006). 
2. Epidemiology (prevalence and incidence) 
Previously, ACD was once wrongly considered uncommon in the pediatric population 
(Hjorth, 1981). It was thought that children had reduced exposure to contact allergens 
during childhood. The second reason was less susceptibility of the child immune system to 
contact allergens (Mortz & Andersen, 1999). However, during the last 10-20 years, several 
reports have described a considerable number of children with CA and ACD (Pevny et al., 
1984a; Pevny et al., 1984b; Weston & Weston, 1984; Rademaker & Forsyth, 1989; Barros et al., 
1991; Dotterund & Falk, 1995; Motolese et al., 1995; Katsarou et al., 1996; Rudzki & 
Rebandel, 1996; Stables et al., 1996; Manzini et al., 1998; Brasch & Geier, 1997), confirming 
that CA and ACD may be frequent in children and may cause significant problems. 
Prevalence of positive patch tests without clinical correlation (CA) in population-based 
studies is different from the prevalence of ACD (positive patch test with clinical correlation) 
in patients referred for patch testing.  
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2.1 Prevalence of contact allergy in a selected population 
Patch test studies in series of selected children with suspected ACD have reported 
frequencies of positive reactions varying from 14% to 71% of patients. Of these, about 56-
93% was of current relevance (Weston & Weston, 1984; Pevny et al., 1984b; Fisher, 1994a; 
Rudzki & Rebandel, 1996; Stables et al., 1996; Manzini et al., 1998; Bruckner  et al., 2000; 
Machovcová et al., 2001; Wöhrl et al., 2003; Heine et al., 2004; Lewis et al., 2004; Jøhnke et al., 
2004; Vozmediano & Hita, 2005; Wahlberg & Lindberg, 2006;  Goossens & Morren, 2006; 
Jacob et al., 2008). Among the children with a positive patch test 3.2% to 54.4% had multiple 
contact allergies (Mortz & Andersen, 1999).  
2.2 Prevalence of contact allergy in an unselected population 
In the general pediatric population, the prevalence of ACD may be underestimated, which 
can be attributed to the low frequency of patch tests performed on children (compared to 
adults) and by the fact that in clinical practice, manifestations of ACD are often attributed to 
morphological look-alikes, such as atopic dermatitis (AD) or irritant dermatitis (Militello et 
al., 2006). The results from patch testing in children and adolescents in the general 
population revealed that 13-24.5% had positive patch tests to standard allergens. The 
prevalence of past or current relevant reactions was found to be 7%, with a higher risk seen 
in females (Dotterund & Falk, 1995; Bruckner et al., 2000; Mortz et al., 2001; Jacob et al., 
2008). Few population-based studies have examined contact sensitization in asymptomatic 
healthy children. Barros et al. (Barros et al., 1991) patch tested 562 Portuguese school 
children (5-14 years old) with 25 allergens. Positive reactions were seen in 13.3%. Multiple 
sensitivities were seen in 2% of the children. Dotterud et Falk (Dotterund & Falk, 1995) 
patch tested 424 Norwegian school children (7-12 years old) with 20 allergens. One or more 
positive reactions were seen in 23.3%. Multiple sensitivities were seen in 8.5% of the 
children. Weston et al. (Weston et al., 1986) patch tested 314 otherwise healthy American 
children and adolescents under the age of 18 years with 20 allergens. He found at least one 
positive patch reaction in 20%. In Bruckner et al. (Bruckner et al., 2000) population-based 
study of 95 healthy asymptomatic children aged 6 to 67.5 months was showed that the 
prevalence of sensitization was 24.5% (≥ 1 positive reaction to an allergen). In our group of 
Czech schoolchildren, positive reactions were detected in 30.7%. Multiple sensitivities were 
seen in 8.7%. The relevance of reactions was 61% (Machovcová, 2006). 
2.3 Prevalence related to sex 
Sex may also play a role on the different prevalence in children. While some authors 
(Weston et al., 1986; Barros et al., 1991; Stables et al., 1996) detected similar prevalence in 
both boys and girls, other (Dotterund & Falk, 1995; Wantke et al., 1996; Goossens & Morren, 
2006) reported a higher prevalence in girls. This is especially the case for nickel (Brasch & 
Geier, 1997; Wöhrl et al., 2003) and after the age of 12 (Rademaker & Forsyth, 1989; Rudzki 
& Rebandel, 1996; Katsarou et al., 1996; Goossens & Morren, 2006). Brasch & Geier (Brasch & 
Geier, 1997) found significantly more girls than boys reacted to nickel (25.0% vs. 4.5%). 
Hormonal factors may be a contributory factor here (Brasch & Geier, 1997; Goossens & 
Morren, 2006).     
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2.4 Prevalence related to age 
Sensitization to contact allergens begins in infancy and continues to be more common in 
toddlers and young children (Seidenari et al., 1992; Giordano-Labadie et al., 1999; 
Vozmediano & Hita, 2005; Militello et al., 2006; Clayton et al., 2006; Garg et al., 2009; De 
Waard-van der Spek & Oranje, 2009), the age of sensitization can occur very early. In study 
of Bruckner et al. (Bruckner et al., 2000), 45% of patients with positive reactions were 
younger than 18 months. Even neonates may be sensitized (Fisher, 1994a; Bruckner et al., 
2000). Fisher (Fisher, 1994a) reported a 1-week-old infant with strongly positive patch test 
reaction to epoxy resin, manifesting as band-like dermatitis above the wrist because of vinyl 
band that was made of an epoxy resin. A 7-month-old child has revealed ACD from nickel–
plated snaps on the back (Fisher, 1994a). Motolese et al. (Motolese et al., 1995) studied 53 
infants (3 months to 2 years) with dermatitis and patch tested them. Positive patch tests 
were seen in 32 (60%) and 20 out of the 32 sensitized infants had clinically relevant contact 
allergies. Hjorth (Hjorth, 1981) thought that patch test reactions in infants were 
predominantly irritant reactions, especially when testing with nickel sulfate. In a study of 
Jøhnke et al. (Jøhnke et al., 2004) it was confirmed that increasing numbers of infants 
positively patch tested to nickel sulfate but most reactions were transient and probably 
irritant or non-specific nature. Experimental CA to plants of the Rhus genus has also been 
induced in infants, showing that sensitization is possible (Epstein, 1961). Manzini et al. 
(Manzini et al., 1998) reported that the highest sensitization rate was noted in children aged 
up to 3 years. It is still unclear why some sensitivities, for example nickel, are prevalent in 
the young but less common in the old. Possible explanations include changing trends in 
exposure to nickel (i.e. increased use of imitation jewellery and different frequencies of ear 
piercing in different generations) or loss of clinical allergy because of avoidance, induction 
of tolerance, or inability to mount an immune response despite continuing exposure (Garg 
et al., 2009). Recall studies showed persistence of CA to nickel after 8 years in 79% and 60% 
to other allergens (Nielsen et al., 2001; Garg et al., 2009). Others found that lanolin, only 41% 
had persistent allergy at 5 years (Carmichael et al., 1991). The increase in fragrance allergy 
with age may be because of cumulative exposure to toiletries and increased use of 
medicaments (Garg et al., 2009). 
3. Contact sensitisation and atopic dermatitis  
The relationship between CA and atopy is frequently discussed and still not settled 
(Rystedt, 1985; Schnuch et al., 2006). Several studies have been performed in children with 
suspected CA or suffering from AD or chronic dermatitis. Patch testing in symptomatic 
children with dermatitis has revealed positive reactions in 15% to 52% of subjects 
(Rademaker & Forsyth, 1989; De Groot, 1990; Katsarou et al., 1996; Rudzki & Rebandel, 1996; 
Stables et al., 1996; Shah et al., 1997; Vozmediano & Hita, 2005; Goossens & Morren, 2006; 
Wahlberg & Lindgerg, 2006). Some authors have indicated that ACD is less prevalent in 
patients with AD (Uhr, 1960; Rystedt, 1985; De Groot, 1990; Katsarou et al., 1996; Stables et 
al., 1996; Brasch & Geier, 1997). Several authors were unable to detect differences between 
atopic and nonatopic subjects in this regard (Marghescu, 1985; Pambor et al., 1991; Goossens 
et al., 1995; Akhavan & Cohen, 2003; Beattie et al., 2007; Milingou et al., 2010). Against this 
others have even found a greater prevalence of ACD in patients with AD (De la Cuadra et 
al., 1990; Lammintausta et al., 1992; Dotterund & Falk, 1995; Lugovic & Lipozencic, 1997; 
Giordano-Labadie et al., 1999; Clayton et al., 2006).  A higher prevalence of CA in AD could 
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be explained by the alterations of the epidermal barrier and the greater permeability of 
irritated skin in AD that favours sensitization to ACD (Dotterund & Falk, 1995; Vozmediano 
& Hita, 2005). Moreover, patients with AD are chronically exposed to potentially more 
sensitizers because of the topical medications used for their skin (Giordano-Labadie et al., 
1999; Vozmediano & Hita, 2005; Clayton et al., 2006). Also there exists a higher probability 
of false positive results in the patch tests conducted in patients with AD (Lammintausta et 
al., 1992; Mortz et al., 2001). Seguraro Rodriguez et al. (Segurado Rodriguez et al., 2004) 
found that a family history of AD (85%), female sex (74%) and age 11-16 (63%) were 
predisposing risk factors to sensitization. On the other hand, Giordano-Labadie et al. 
(Giordano-Labadie et al., 1999) systematically evaluated contact sensitization in a series of 
atopic pediatric patients. It was observed that 43% of the 114 children who patch tested had 
positive reactions without association with AD. From Vozmediano’s (Vozmediano & Hita, 
2005) point of view, AD did not affect the sensitization to the different allergens, although a 
higher number of irritative responses or false positives were frequently observed. Onder and 
Adisen reported only 0.3% of the patients having AD and positive patch test reactions in their 
study in a pediatric population in Turkey (Onder & Adisen, 2008). 
4. Clinical presentation 
The clinical characteristics of ACD are the same in children as in adults (Militello et al., 2006; 
Goossens & Morren, 2006). The classical clinical presentation of ACD is pruritic eczematous 
dermatitis. The location can be important for identification of the causal allergen since 
contact dermatitis is generally restricted to the contact site. Textile allergens usually cause 
dermatitis in areas in which the garment continually rubs against the skin, such as sub-
axillary and/or flexural areas of the extremities. Cosmetic allergens tend to produce facial, 
neck or periorbital dermatitis. Shoe allergens often present on the dorsum of the feet 
(Goossens, 2001; Militello et al., 2006; Goossens & Morren, 2006).  Spreading of the 
dermatitis, often in the form of small papules, may occur far from the original contact site 
and may be generalized. This can be explained by hematogenous dissemination of the 
allergens (Goossens, 2001) or by contact with allergenic or allergen-contaminated surfaces, 
transfer of an allergen via the hands to the face or other sites, which gives rise to an ‘ectopic’ 
contact dermatitis. CA can be caused also by products that have come in contact with the 
parents or other persons in the environment of the children (‘connubial’ or ‘consort’ 
dermatitis). The ‘ectopic’ or ‘connubial’ reactions are commonly involved the skin of the 
eyelids or neck. Additionally, distant or widespread eruptions (commonly referred to as ‘Id’ 
reactions) can often be triggered by localized ACD to such chemicals as nickel and poison 
ivy (Goossens, 2001; Militello et al., 2006; Goossens & Morren, 2006). Untreated reactions 
from highly potent allergens, such a poison ivy, can be severe and last for several weeks 
(Militello et al., 2006). Continued exposure even to low levels of allergen can perpetuate 
these skin eruptions indefinitely.  Recognizing potential pediatric patients with ACD either 
as the primary diagnosis or the confounding factor is crucial. Often the findings are difficult 
to distinguish, clinically and histopathologically, from AD or irritant dermatitis (Goossens, 
2001; Militello et al., 2006; Goossens & Morren, 2006).  
5. Diagnosis and patch testing in children 
Diagnosis rests on taking a substantial clinical history. Essential is an extensive and 
standardized anamnesis that covers all possible etiological factors like hobbies, leisure time 
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activities, use of topical pharmaceutical products and cosmetics and contact with plants 
(Goossens, 2001). The children and their parents can themselves provide many indications 
but often need to be convinced that the allergenic product may not have been introduced 
only recently into their environment. Indeed, it can take several days before the clinical 
symptoms and signs appear after the contact. The delay in reaction by 24-48 hours after 
allergen exposure can make difficulties to establish (Goossens, 2001). Children and their 
parents are not typically aware of this delay in reaction and often search for immediate 
associations. A detailed history of events during the week preceding the onset of symptoms 
is vital (Militello et al., 2006).  
The gold standard for definitive diagnosis of ACD is epicutaneous patch testing (Militello et 
al., 2006; Goossens & Morren, 2006). Most authors agree that the patch testing in children is 
safe (Weston et al., 1989; Rademaker & Forsyth, 1989; Fisher, 1994b; Goossens & Morren, 
2006), the only problems being mainly technical due to small patch test surface (Rademaker 
& Forsyth, 1989; Goossens & Morren, 2006), hypermobility, particularly in smaller children 
(Shah et al., 1997; Goossens & Morren, 2006). Patch testing involves the placement of a small 
amount of potential allergens under occlusion on the patient’s back. These patches are 
typically removed after 48 hours and an initial reading is performed. A delayed reading at 
72 and/or at 96 hours is recommended. Positive reactions are evaluated according to the 
criteria of the International Contact Dermatitis Research Group as – (negative), +- (doubtful) 
and +, ++, +++ (weak, moderate and strong reaction, respectively) depending on the grade 
of erythema, induration or blistering that occurs at the site of allergen placement (Wahlberg 
& Lindgerg, 2006). The patch test concentrations have been discussed in detail in the 
literature (Goossens & Morren, 2006). Some authors have recommended lower 
concentrations (Hjorth, 1981; Pambor et al., 1991), particularly with regard to specific 
allergens such as nickel and formaldehyde (Fisher, 1991), mercurials (Fisher, 1994b), 
potassium dichromate and thiuram mix (Fisher, 1994b). The others use the same test 
concentrations as those used in adults (Pevny et al., 1984a; Pevny et al., 1984b; Stables et al., 
1996; Seidenari et al., 1992; Motolese et al., 1995; Worm et al., 2007).  
Children should be tested strictly based on the indication using a standard protocol. A 
negative patch test result does not exclude contact dermatitis. False-negative reactions have 
various causes, often ′missed′ allergen, which may be picked up by detailed questioning 
(Goossens, 2001; Goossens & Morren, 2006). For the skin tests, the possible risks of overlooking 
a CA are thus centred on the allergen itself, the test method, the test concentration and vehicle 
used, the time of reading and, finally, the relevance (Goossens, 2001).   
6. Clinical relevance 
Contact sensitization, however, does not necessarily equate with clinical diseases. Clinical 
relevance of allergic reactions on patch testing was determined according to the clinical 
history, type of dermatitis and the allergen concerned. Relevance of allergens should be 
determined for all patients with one or more positive reactions. Clinical relevance was 
confirmed if the allergen was found to be present in the patient’s environment, the 
dermatitis corresponded to point(s) of contact with the allergen and the dermatitis 
significantly improved upon isolation of the allergen, or recurred with re-challenge (positive 
use test) (Jacob et al., 2008).  Reported clinical relevance in children has been varied between 
20% and 93% (Pevny et al., 1984b; Rademaker & Forsyth, 1989; Pambor et al., 1991; Stables, 
1996; Mortz & Andersen, 1999).  
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7. The common allergens in children 
Nickel is always the most common allergen in children, followed by cobalt, mercurials 
(thimerosal and metallic mercury), rubber chemicals (thiuram mix, carba mix, mercapto mix 
and mercaptobenzothiazole, PPD) and fragrance mix. The most frequent sources are 
costume jewellery (nickel in earrings), medications, footwear, cosmetics and plants 
(Rademaker & Forsyth, 1989; Barros et al., 1991; Stables et al., 1996; Militello et al., 2006; 
Goossens & Morren, 2006).    
7.1 Nickel 
Nickel is by far the most common allergen in patients of all ages, including children. Nickel 
was the top allergen in children in 14 of the 17 studies of patch testing summarized by 
Mortz and Andersen (Mortz & Andersen, 1999). Even in younger children nickel allergy is 
not uncommon (Jøhnke et al., 2004). Published rates of nickel sensitization in children range 
between 10% and 24% (Wöhrl et al., 2003; Heine et al., 2004; Lewis et al., 2004;  Seidenari et 
al., 2005; Vozmediano & Hita, 2005; Clayton et al., 2006; Militello et al., 2006; Goossens & 
Morren, 2006; Milingou et al., 2010). Ear piercing along with atopy is regarded as a major 
risk factor for the development of nickel sensitization, especially in girls (Militello et al., 
2006; Goossens & Morren, 2006). Nickel sensitization sources in children are numerous: 
jewellery (earrings), jean studs, belt buckles, zippers or buttons (Clayton et al., 2006). 
Sensitization to nickel is not necessarily followed by ACD, but infants with a reproducible 
positive reaction to nickel sulfate could represent a group at risk of developing clinically 
manifest nickel dermatitis later in life (Magnusson & Moller, 1979). In agreement with 
earlier studies in older children and adults (Dotterund & Falk, 1995; Mortz et al., 2001; Uter 
et al., 2004; Jøhnke et al., 2004), a female predominance of positive reactions to nickel sulfate 
was found in infants (girls 13.1% and boys 4.0%). Despite a marked decrease in nickel 
allergy and nickel dermatitis in young women after nickel regulation came into force 
(Schnuch & Uter, 2003; Thyssen et al., 2009; 2011), the prevalence of nickel allergy remains 
very high, and seems to have stabilized at a high level (Schnuch et al., 2011). However, 
women who were ear-pierced after regulatory intervention in Denmark had a significantly 
lower prevalence of nickel allergy and dermatitis than women who were ear-pierced before 
(Thyssen et al., 2009; 2011). It is important to emphasize that nickel allergy remains very 
prevalent in some European countries. The proportion of positive patch test reactions to 
nickel sulfate has remained stable at 10%-20% among young female German dermatitis 
patients (< 18 years) since the beginning of the new millennium (Schnuch et al., 2011). The 
2005-2006 clinical patch test data registered in 10 European countries and reported to the 
European Surveillance System on Contact Allergies revealed high prevalence of nickel 
allergy in western, southern, central and north-eastern Europe, being, respectively, 20.8%, 
24.5%, 19.7% and 22.4% (Uter et al., 2009). There may be several explanations for this finding 
(Thyssen et al., 2011), but it is generally accepted that excessive nickel release from 
consumer items is one of the most important single factors (Schnuch & Uter, 2003). 
7.2 Thiomersal and metallic mercury 
Sensitization to thiomersal (an organic mercurial compound) is frequently observed in 
infants and children. The widespread use as a preservative in a variety of compounds, 
including vaccine and antitoxin preparations, ophthalmic drops and contact lens solutions, 
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may explain the high rate of positive patch test reactions (Katsarou et al., 1996; Militello et 
al., 2006; Goossens & Morren, 2006; Milingou et al., 2010). Low clinical relevance along with 
sensitization rates is probably related to its presence in vaccines (Novák et al., 1986; Osawa 
et al., 1991; Lee et al., 2009). Recently, percentages of sensitization in children have increased 
from 2.3% (Barros et al., 1991) to 10% (Möller, 1997) due to iatrogenic sources (antiseptics, 
topical medications, thermometers and vaccines) and footwear (Novák et al., 1986; Osawa et 
al., 1991; Militello et al., 2006; Goossens & Morren, 2006; Lee et al., 2009). 
7.3 Topical antibiotics 
Neomycin, bacitracin and gentamycin are topical antibiotics with high rates of allergic 
contact sensitization in children (Heine et al., 2004; Seidenari et al., 2005; Jacob et al. 2008). 
Neomycin sulfate has remained second place in the most common culprits in ACD for close 
to 25 years (Spann et al., 2003; Lee et al., 2009). It is a topical antibiotic with multiple clinical 
indications, including use for superficial wounds or burns and can be found in many over-
the-counter products in the US or Europe. It is also formulated in combinations with other 
antibiotics, antifungals or corticosteroids (Lee et al., 2009). Menezes de Pádua et al. (Menezes 
de Pádua et al., 2005) found 2.5% positive reactions to neomycin, while in 1.1%, ACD was 
additionally diagnosed. 
7.4 Cosmetics allergens 
The market for cosmetic products specially formulated for children is expanding and usage 
of cosmetics being seen to increase in children. Consequently, one can expect cosmetics to 
become more important causes of ACD in children (Goossens et al., 2002). At least one 
cosmetic or cosmetic ingredient gave a positive reaction in 30% of the children investigated 
(Goossens et al., 2002; Goossens & Morren, 2006). Almost every ingredient may be 
responsible for cosmetic dermatitis (Goossens et al., 2002; Goossens & Morren, 2006). Fisher 
(Fisher, 1995) further stated that children often become allergic to cosmetics used by the 
mother or the person taking care of them. The localizations often involved seem to be the 
forehead and the cheeks, with perfume, lipstick, hairspray or nail lacquer as the responsible 
agents (Fisher 1995; Goossens et al., 2002; Buckley et al., 2003; Goossens & Morren, 2006). 
However, children often use cosmetic products themselves and this may not always be 
revealed immediately (Goossens et al., 2002; Goossens & Morren, 2006). 
7.4.1 Fragrances 
The use of cosmetic products in babies and young children can cause perfume allergy 
(Fisher 1995; Goossens et al., 2002; Buckley et al., 2003; Goossens & Morren, 2006). A large 
numbers of perfumed products are marketed especially for children (Rastogi et al., 1999; 
Kohl et al., 2002). Fragrance allergy is increasingly common and even young children are 
exposed (Rastogi et al., 1999). Exposure is usually due to perfumes or to other aromatic 
topical products such as moisturizers or deodorants. Typical sites of involvement include 
face, neck and axillae, in addition to full systemic contact dermatitis (Tomar et al., 2005; 
Garg et al., 2009; Lee et al., 2009). Fragrance allergy is usually detected by patch testing to 
three mixtures of scented compounds: Fragrance Mix I, Fragrance Mix II and Myroxylon 
pereirae tree extract (Balsam of Peru). The rate of sensitization to fragrance appears to 
increase with age (Buckley et al., 2003; Lee et al., 2009). The Myroxylon pereirae tree extract 
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(Balsam of Peru) is used as a screen for fragrance allergy, due to its wide usage and natural 
cross-reactivity with other frequently encountered fragrances (Tomar et al., 2005; Garg et al., 
2009; Lee et al., 2009). These allergens (or chemically similar ones) are also used in soft 
drinks and flavouring such as cinnamon, cloves, curry and vanilla. Although dietary 
intervention remains controversial, there is evidence that it may help those with significant 
disease that is not resolving with more typical fragrance avoidance (Magnusson & 
Wilkinson, 1975; Salam & Fowler Jr., 2001; Tomar et al., 2005). Although guidelines for the 
maximum concentration of preservatives and fragrances in cosmetics have been provided 
(Goossens et al., 2004), it has been demonstrated that toys may contain much higher 
concentrations of fragrance (Rastogi et al., 1999). No extra safety requirements for toys 
intended for children are required (White, 2000). 
7.4.2 Preservatives 
Conti et al. (Conti et al., 1997) reviewed contact sensitization to 8 preservatives 
(imiadazolidinyl urea, diazolidinyl urea, parabens, formaldehyde, quaternium-15, Katon 
CG, Euxyl K400 and butylated hydroxyanizole) in the child population and found 7.3% of 
the children reacted positively. Almost 50% of preservative-sensitive children had AD. Baby 
toilet tissues have been occasionally reported to cause CA in babies and those who take care 
of them. The allergens considered most often are fragrances and preservatives. 
Methylchloroisothiazolinone and methylisothiazolinone (MCI/MI) is widely used as a 
preservative in many products (De Groot & Herxheimer, 1989). Tosti et al. (Tosti et al., 2003) 
found MCI/MI to be a frequent cause of ACD, i.e. in 7 of 95 children between 3 and 11 years 
old were positive to MCI/MI. The use of moist toilet papers (baby wipes) can be responsible 
for ACD, especially of perianal area (De Groot et al., 1991). MCI/MI was replaced from 
them by other preservatives, particularly with Euxyl K400 (methydibromoglutaronitrile and 
phenoxyethanol) (Senff et al., 1989) and 1,2-dibromo-2,4-dicyanobutane (Van Ginkel & 
Rutdervoort, 1995). 
7.4.3 Sorbitan sesquioleate 
De Waard-van der Spek and Oranje (De Waard-van der Spek & Oranje, 2009) found 3 
children patch tested positive to sorbitan sesquioleate (SSO), all clinically relevant. Two 
children used emollient contained SSO as emulsifier. They also reported a child positive 
patch tested to Adaptic non-adhering dressing containing SSO. Castanedo-Tardan and Jacob 
(Castanedo-Tardan & Jacob, 2008) reported the case series of 6 pediatric patients with 
clinically relevant contact allergy to SSO. 5 children were atopics and suffered with 
recalcitrant dermatitis. 
7.5 Para-Phenylenediamine and tattoos 
An increased prevalence of para-Phenylenediamine (PPD) allergy has been noted in the 
pediatric population. Eczematous reactions are mostly seen at the site of the tattoo and they 
may be long-lasting (Lewis et al., 2004). Henna dye is a dark green powder, used for hair 
dyeing and body tattooing. Henna itself is relatively safe. However, PPD is added on an 
illegal basis in semi-permanent tattoos (black henna tattoos), in order to obtain a darker 
colour and a faster drying time than natural henna can provide. Although many parents and 
consumers believe these black henna tattoos to be temporary, adverse events to them 
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(scaring and sensitization) can be permanent.  PPD is a very potent contact sensitizer 
included in the European baseline series for patch testing. PPD is also contained in 
permanent hair dyes and related compounds (Lee et al., 2009). The content of PPD in semi-
permanent tattoo ink has been reported to vary between 0.4 and 15.7%, far exceeding the 
limit permissible for hair dyes (<6%) (Brancaccio et al., 2002; Avnstorp et al., 2002; Sosted et 
al., 2006; Lee et al., 2009). The long duration of skin contact, the high concentrations of 
sensitizing materials (diaminobenzenes or diaminotoluenes) and the lack of a neutralizing 
agent increase the risk of skin sensitization. Because of the worldwide vogue for skin 
painting, a greater number of patients sensitized to PPD and diaminobenzenes or 
diaminotoluenes can be expected (Le Coz et al., 2000; Onder et al., 2001; Neri et al., 2002; 
Jovanovic & Slavkovic-Jovanovic, 2009). The unusually severe reactions to PPD in young 12  
to 15 year old adolescents have occurred after dyeing their hair having been previously 
sensitized to PPD in black henna tattoo at a younger age. In some cases, the children 
developed severe angioedema-like reactions necessitating admission to hospital and 
intensive care treatment (Sosted et al., 2006). Severe allergic reactions were reported in 1.4% 
of women and 1.3% of men after dying their hair (Sosted et al., 2005). Sensitization to PPD is 
potential for lifelong sensitization and systemic contact dermatitis can be evoked with 
exposure to cross-reactors such as benzocaine, diuretics (hydrochlorothiazide) and 
sulfonamide medications (Sosted et al., 2006; Lee et al., 2009). Notably, 25% of those allergic 
to PPD can also be reactive to semi-permanent dyes found in synthetic clothing. PPD base, 
being a part of the European baseline series, is regarded as a screening agent for contact 
allergy to para and azo compounds in hair dyes, but not for textile and leather dye allergy 
(Koopmans & Bruynzeel, 2003). 
7.6 Rubber compounds 
Rubber additives are typically present in many rubber products (e.g. elastic waistbands, 
socks, swimwear, shoes, toys, cosmetic applicators and adhesives) and could be main 
allergens from them. Thiurams, mercapto chemicals and less commonly carbamates are the 
responsible allergens in rubber allergy in children; thiourea derivates in neoprene may also 
be the cause of dermatitis (Goossens & Morren, 2006; Lee et al., 2009). Roul et al. (Roul et al., 
1998) reported a particular type of diaper dermatitis called 蠑Lucky Luke蠖 dermatitis. The 
rubber parts used for a new anti-leaking system in these diapers provoked the reaction. 
Mercaptobenzothiazole and thiuram derivates are also present in certain types of glues 
(Roul et al., 1996; Cockayne et al., 1998). Type I allergic reactions may also occur (contact 
urticaria syndrome), sometimes associated with a type IV reaction. It is typical for children 
who had undergone multiple surgical operations (for example children suffering from spina 
bifida). Moreover, these children are particularly susceptible to natural rubber latex proteins 
in this regard (Goossens & Morren, 2006). 
7.7 Toxicodendron dermatitis (Poison Ivy, Poison Oak, Poison Sumac) 
Toxicodendron (Poison Ivy) dermatitis can occur at any age, although infants are apparently 
not as easily sensitized as adults. After the age of 3, children become highly susceptible and 
by 12 years of age nearly all have become sensitized to poison ivy (Kligman 1974). Plants 
belonging to the Rhus family are the ones most often involved in ACD among children 
living in the United States (Goossens & Morren, 2006). The oleoresin (urushiol) of the sap of 
the Toxicodendron plants contains catechols, which are very strong sensitizing chemicals. The 
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eruption produced by poison ivy is characterized by redness, papules, vesicles and bullae 
plus linear streaking. Occasionally, urticaria and eruptions, resembling erythema 
multiforme, measles or scarlatina, occur from systemic absorption of the poison ivy antigen 
(Rietschel & Fowler Jr., 2008b). Exposure can be direct or indirect, such as transfers of the 
allergen via animals, tools, clothing, golf clubs, etc. (Goossens & Morren, 2006; Rietschel & 
Fowler Jr., 2008b), which is more difficult to diagnose (Epstein 1971). A few cases of 
phytophotodermatitis from Toxicodendron in children were also reported (Goossens & 
Morren, 2006).  
8. Treatment 
The cornerstone of treatment of ACD is proper allergen avoidance. Once an allergen is 
identified, patients must be educated on potential exposures, cross-reacting chemicals, 
preventive measures, as well as offered suggestions for avoidance. This may be especially 
difficult in households with small children affected, as the products that are used by the 
patents and sibling may also need to be considered as sources for allergen exposures.  
Emollients can be added after a bath in an effort to retain hydration and restore the barrier 
function of the skin. Barrier repair also decreases pruritus and reduces visible scaling and 
dryness. Physical barrier creams may be useful in cases in which the allergen exposure 
cannot be avoided. Patients should apply the creams before and during the exposure in an 
effort to decrease absorption (Lee et al., 2009).  
Topical corticosteroids are the first-line treatment modality for mild cases of ACD but they 
are not without risk and can cause multiple cutaneous side effects with extensive and long 
term use (Militello et al., 2006; Goossens & Morren, 2006; Jacob & Castanedo-Tardan, 2007; 
Lee et al., 2009). When selecting a topical corticosteroid for treatment, it is important to 
choose one that the patient is not allergic to in terms of the active ingredient (the steroid 
component) and inactive ingredients in the vehicle (Lee et al., 2009). As with any topical 
steroid, the risk of atrophy, teleangiectasias, tachyphylaxis and systemic absorption should 
be kept in mind, especially in areas of increased sensitivity such as face, groin and flexural 
area (Militello et al., 2006). 
Topical calcineurin inhibitors (TCIs) are another therapeutic option and should be 
considered when steroid-sparing agents are required. These agents can be used for certain 
areas, such as the face, axilla and groin, which are more susceptible to steroid-induced 
atrophy (Lee et al., 2009). 
In cases of widespread and severe reactions, Militello et al. (Militello et al., 2006) 
recommended at least 3 weeks of oral prednisone in combination with topical therapy. 
Shorter courses often lead to rebound flares of the dermatitis. Systemic corticosteroids are 
generally started at 1 mg/kg per day (Brasch, 2009). Oral H1-antihistamines are widely used 
as an adjuvant nonspecific treatment for pruritus in infants and children. They also cause 
drowsiness that may help with sleeping disturbances from pruritus (Militello et al., 2006; 
Lee et al., 2009).  
9. Conclusions 
ACD in infancy is more frequent than was initially suggested, although its true prevalence 
and incidence continue to be unknown. Age and sex influence its development, but the 
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principal factor associated with ACD is the pattern of exposure to the various allergens 
(Vozmediano & Hita, 2005). In the unselected population, the prevalence of CA is about 20% 
(Mortz & Andersen, 1999; Weston & Weston, 1984; Barros et al., 1991), while in the selected 
population, the prevalence of ACD is found to be variable, with a mean of 40% (Mortz & 
Andersen, 1999; Wöhrl et al., 2003; Heine et al., 2004; Lewis et al., 2004; Seidenari et al., 2005; 
Vozmediano & Hita, 2005; Militello et al., 2006;  Goossens & Morren, 2006; Jacob et al., 2008). 
The susceptibility to contact sensitization increases with the age. The most important 
allergens observed in this population are metals, mercury, pharmaceutical products and 
cosmetics (Vozmediano & Hita, 2005; Militello et al., 2006; Goossens & Morren, 2006; Jacob 
et al., 2008).  ACD in childhood may also affect decisions regarding future occupations in 
adulthood. Therefore, it is very important that any CA in a child is recognized and dealt 
with in time. The impact of CA must not be underestimated, both on a complex individual 
scale of quality of life and socio-economically, for example, due to job options (Uter et al., 
2004). Patch testing is both well tolerated and diagnostically essential in the evaluation of 
pediatric patients with potential ACD. Once allergen is documented, treatment relies on 
symptomatic use of topical or oral corticosteroids and meticulous allergen avoidance 
(Militello et al., 2006). Good information on preventing the development of ACD in children 
is useful for the caregivers.  
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